Share this postExperimental Gene TherapyEfficacy of BNT162b2 Questioned after Review of Phase 3 Data using Nucleocapsid Antibody DataCopy linkFacebookEmailNotesMoreEfficacy of BNT162b2 Questioned after Review of Phase 3 Data using Nucleocapsid Antibody DataThis thread by "Jikkyleaks" presents an analysis of Pfizer Phase 3 Trial using Pfe's nucleocapsid antibody data. Phil Harper verifies the analysis.Robert W. Chandler, MD MBAJul 27, 20222Share this postExperimental Gene TherapyEfficacy of BNT162b2 Questioned after Review of Phase 3 Data using Nucleocapsid Antibody DataCopy linkFacebookEmailNotesMoreShareThis thread was censored on Twitter where it originally was published. It was later archived on Telegram but is no longer available. It is presented here as an act of preservation.Jikky And Harper7.55MB ∙ PDF fileDownloadDownload Thanks for reading Experimental Gene Therapy! Subscribe for free to receive new posts and support my work.Subscribe
